Additional file 3: Table S1. of Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies

Abstract

Dose-response relationship of MOLP-8 tumours to indatuximab ravtansine alone, lenalidomide alone and combination therapy. (DOCX 12 kb